ATE185973T1 - Verwendung von humanem atrio-natriuretischem peptid zur herstellung eines medikaments zur behandlung des atemunwohlseinsyndroms bei erwachsenen - Google Patents

Verwendung von humanem atrio-natriuretischem peptid zur herstellung eines medikaments zur behandlung des atemunwohlseinsyndroms bei erwachsenen

Info

Publication number
ATE185973T1
ATE185973T1 AT93100032T AT93100032T ATE185973T1 AT E185973 T1 ATE185973 T1 AT E185973T1 AT 93100032 T AT93100032 T AT 93100032T AT 93100032 T AT93100032 T AT 93100032T AT E185973 T1 ATE185973 T1 AT E185973T1
Authority
AT
Austria
Prior art keywords
treatment
natriuretic peptide
human
syndrome
unason
Prior art date
Application number
AT93100032T
Other languages
English (en)
Inventor
Masakazu Toutate New Hait Ueda
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE185973T1 publication Critical patent/ATE185973T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
AT93100032T 1992-01-09 1993-01-04 Verwendung von humanem atrio-natriuretischem peptid zur herstellung eines medikaments zur behandlung des atemunwohlseinsyndroms bei erwachsenen ATE185973T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4002424A JP2925391B2 (ja) 1992-01-09 1992-01-09 Ａｒｄｓ治療用医薬組成物

Publications (1)

Publication Number Publication Date
ATE185973T1 true ATE185973T1 (de) 1999-11-15

Family

ID=11528876

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93100032T ATE185973T1 (de) 1992-01-09 1993-01-04 Verwendung von humanem atrio-natriuretischem peptid zur herstellung eines medikaments zur behandlung des atemunwohlseinsyndroms bei erwachsenen

Country Status (8)

Country Link
US (1) US5418219A (de)
EP (1) EP0551077B1 (de)
JP (1) JP2925391B2 (de)
AT (1) ATE185973T1 (de)
DE (1) DE69326849T2 (de)
DK (1) DK0551077T3 (de)
ES (1) ES2141116T3 (de)
GR (1) GR3032442T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5504111A (en) * 1994-12-30 1996-04-02 Medichem Research, Inc. Use of 2,3 alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
US5780440A (en) * 1996-06-17 1998-07-14 Protease Sciences Inc. Treatment of pulmonary disease with protease inhibitors
CA2365233C (en) * 1999-12-28 2013-03-12 Sony Corporation Signal processing device and method, and recording medium
IL145926A0 (en) * 2001-10-15 2002-07-25 Mor Research Applic Ltd Peptide epitopes of mimotopes useful in immunomodulation
IL155136A0 (en) 2003-02-10 2003-10-31 Enzymotec Ltd A composition for reducing blood cholesterol and triglycerides
US20060233863A1 (en) 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
KR20060018267A (ko) * 2003-06-13 2006-02-28 다이이치 아스비오파마 가부시키가이샤 Ｔｈ１형 면역질환의 예방 또는 치료용 약학 조성물
KR101268206B1 (ko) * 2004-08-09 2013-05-27 엔지모테크 리미티드 당뇨병용 식품
EP1796726A2 (de) 2004-08-10 2007-06-20 Enzymotec Ltd. Gemisch aus phytosterolestern und 1,3-diglycerid(en) zur behandlung von medizinischen krankheiten
WO2007000768A2 (en) * 2005-06-28 2007-01-04 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Gliomedin, fragments thereof and methods of using same
WO2007030492A2 (en) * 2005-09-06 2007-03-15 Guilford F Timothy Method for the treatment of infection with hhv-6 virus and the amelioration of symptoms related to virus using liposomal encapsulation for delivery of reduced glutathione
CA2647146A1 (en) * 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs
US8580746B2 (en) * 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
CA2647143A1 (en) * 2006-03-30 2007-10-11 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
US20100150924A1 (en) * 2007-05-22 2010-06-17 Elior Peles Regulation of myelination by nectin-like (necl) molecules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60136596A (ja) * 1983-12-26 1985-07-20 Suntory Ltd ペプチド及びこれを有効成分とする利尿剤
DE3443257A1 (de) * 1984-11-28 1986-05-28 Bissendorf Peptide GmbH, 3002 Wedemark Mittel enthaltend vollsynthetisches alpha-humanes atriales natriuretisches peptid (alpha-hanap)
US5043321A (en) * 1988-07-11 1991-08-27 Center For Innovative Technology Adrenocorticotropin release inhibiting factor

Also Published As

Publication number Publication date
EP0551077A3 (en) 1994-06-29
JPH05186366A (ja) 1993-07-27
EP0551077A2 (de) 1993-07-14
ES2141116T3 (es) 2000-03-16
EP0551077B1 (de) 1999-10-27
DE69326849T2 (de) 2000-04-20
JP2925391B2 (ja) 1999-07-28
DK0551077T3 (da) 2000-04-10
GR3032442T3 (en) 2000-05-31
DE69326849D1 (de) 1999-12-02
US5418219A (en) 1995-05-23

Similar Documents

Publication Publication Date Title
ATE185973T1 (de) Verwendung von humanem atrio-natriuretischem peptid zur herstellung eines medikaments zur behandlung des atemunwohlseinsyndroms bei erwachsenen
UA35636C2 (uk) Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців
DE69033040T2 (de) Verfahren zur Herstellung von biologisch aktivem Protein (z.B. TGF)
ATE120644T1 (de) Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
DE69214467T3 (de) Verwendung von L-2-oxo Thiazolidin-4-carboxylat zur Behandlung von Atemnotsyndrom
DE3855113T2 (de) Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
DE59000270D1 (de) Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
GR3026369T3 (en) Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist.
WO1992012715A3 (en) The use of loperamide and related compounds for treatment of respiratory disease symptoms
AT380202B (de) Material zur herstellung von artikeln zur abstuetzung des kopfes oder von gliedmassen des menschen oder von tieren, sowie aus diesem material hergestellte artikel
GR3025488T3 (en) Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
DE69122364D1 (de) Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen
DK0443848T3 (da) Nyt antiulcermiddel
DE69232911D1 (de) Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen
IL98199A (en) Pharmaceutical compositions containing a derivative of substituted l-valyl-l-prolinamide
EP0374089A3 (de) Verwendung von Somatostatinderivaten als Substanzen zum Schutz der Lunge
ATE235238T1 (de) Verwendung von 2,3- alkylcaebonyloxybenzoesäure zur behandlung des atemunwohlseinsydroms bei erwachsenen
ATE173629T1 (de) Hamamelis-trockenextrakt, verfahren zu seiner herstellung und seine verwendung als arzneimittel
ATE184287T1 (de) Derivate von therapeutisch in der blutgerinnungskaskade wirksamen peptiden, verfahren zur herstellung und sie enthaltende pharmazeutische zubereitungen
ATE192650T1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
DE69203098D1 (de) Verwendung eines Polypeptids mit humaner Interleukin-2 Aktivität zur Herstellung pharmazeutischer Zusammensetzungen zur Behandlung von Pneumothoraxen.
DE69431320T2 (de) Verwendung von menschlichem Interferon-d zur Herstellung eines Arzneimittels zur Behandlung von Atemwegserkrankungen in Katzen
ITMI910442V0 (it) Struttura di zoccolo ortopedico, o simile, in particolare per la prevenzione o la cura del valgismo dell'alluce
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.
DE69133298D1 (de) Verwendung von acetylierten Mannanderivaten zur Behandlung von chronischen Atemwegserkrankungen

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee